Newsletter Archive

Blog

SDR-PEP Webinar Series: The Role of Persons Affected in SDR-PEP Implementation

6 November, 2020 | Global Partnership for Zero Leprosy

The Global Partnership for Zero Leprosy, along with WHO Global Leprosy Programme, launched an SDR-PEP-focused webinar series. The first webinar in this series explored the process of starting SDR-PEP implementation for National Leprosy Programmes. The second webinar will address the … More SDR-PEP Webinar Series: The Role of Persons Affected in SDR-PEP Implementation

Read Article >
LPEP Novartis

Contact tracing with prophylactic treatment could near-eliminate leprosy in a single generation, new research suggests

2 November, 2020 | Novartis International AG

Results from the Novartis Foundation-initiated Leprosy Post-Exposure Prophylaxis (LPEP) program covered more than 150,000 people across seven countries Post-exposure prophylaxis with a single dose of the antibiotic rifampicin is safe, can be integrated into different leprosy control programs, and is … More Contact tracing with prophylactic treatment could near-eliminate leprosy in a single generation, new research suggests

Read Article >
Sasakawa Health Foundation Nepal

Grant Program for Organizations of Persons Affected by Leprosy/Hansen’s Disease During the COVID-19 Pandemic

24 September, 2020 | Sasakawa Health Foundation

Sasakawa Health Foundation with support from The Nippon Foundation is implementing a grant program for organizations of persons affected by leprosy/Hansen’s disease to support people who have been severely impacted by the unprecedented crisis caused by the spread of the … More Grant Program for Organizations of Persons Affected by Leprosy/Hansen’s Disease During the COVID-19 Pandemic

Read Article >
Nepali woman receives skin exam

The COVID-19 Crisis and Persons Affected by Leprosy: Questionnaire Results

9 September, 2020 | Global Partnership for Zero Leprosy

The economic, social, and health impacts of the COVID-19 pandemic have led to a significant increase in the need for humanitarian aid and social protection measures. Persons affected by leprosy have been especially impacted by the worst consequences of the pandemic, due to preexisting vulnerabilities and economic precarity.

Governments, NGOs, civil society organizations, and organizations of persons affected by leprosy have enacted policies and programmes intended to support persons affected during this crisis, although there are still gaps. To support the effectiveness of these interventions, and to help raise awareness of resources available to persons affected, the Global Partnership for Zero Leprosy’s COVID-19 Emergency Advocacy Working Group and UN Special Rapporteur on the elimination of discrimination against persons affected by leprosy and their family members Alice Cruz, gathered data on available programmes and resources. The following information was gathered through an online questionnaire from 100+ persons affected and partners, representing 24 countries.

Read Article >
Working with Programs

GPZL’s COVID-19 Working Groups: August 2020 Update

11 August, 2020 | Global Partnership for Zero Leprosy

The COVID-19 pandemic has strongly impacted leprosy control and prevention, and in response, GPZL has established three working groups to address the leprosy community’s key challenges during the global health crisis, and spearhead emergency response. This article is an update on their progress.

Read Article >
Novartis Multi-drug therapy manufacturing

Novartis Kalwe Site Associates Live On-Site during COVID-19 Lockdown to Maintain Multi-Drug Therapy Supply Chain for WHO Donation Program

6 August, 2020 | Global Partnership for Zero Leprosy

The COVID-19 pandemic has halted many leprosy control and prevention activities globally, putting vulnerable communities further at risk. The Novartis Technical Operations (NTO) Sandoz Kalwe site, located north of Mumbai on India’s west coast, faced new challenges beginning earlier this … More Novartis Kalwe Site Associates Live On-Site during COVID-19 Lockdown to Maintain Multi-Drug Therapy Supply Chain for WHO Donation Program

Read Article >

Search for New Project Manager

20 July, 2020 | Global Partnership for Zero Leprosy

The Global Partnership for Zero Leprosy (GPZL) team is growing. We are looking for a new Associate Director of Programs to join the Secretariat. This person will develop, coordinate, and monitor GPZL’s national partnerships. Activities may include an initial assessment … More Search for New Project Manager

Read Article >

GPZL’s 2020 Country Partners

14 July, 2020 | Global Partnership for Zero Leprosy

The Global Partnership for Zero Leprosy (GPZL) is working toward a world without leprosy through a country-by-country strategy. We bring together partners in-country and international stakeholders to work on country-led customized strategies that address local needs and priorities to end … More GPZL’s 2020 Country Partners

Read Article >
Working with Programs

GPZL’s COVID-19 Working Groups: June 2020 Update

16 June, 2020 | Global Partnership for Zero Leprosy

The COVID-19 pandemic has strongly impacted leprosy control and prevention, and in response, GPZL has established three working groups to address the leprosy community’s key challenges during the global health crisis, and spearhead emergency response. This article is an update on their progress.

Read Article >

Thank you to Dr. Christine Fenenga: A foundational contributor to GPZL 

16 June, 2020 | Global Partnership for Zero Leprosy

Dr. Christine Fenenga, MPH, PhD, has has played an important role in the foundation of the Global Partnership, shaping GPZL’s Operational Excellence work since joining the Secretariat in 2018. Her contributions have been essential to the growth and success of this partnership and will be remembered worldwide.

Read Article >
Working with Programs

GPZL’s COVID-19 Working Groups: May 2020 Update

12 May, 2020 | Global Partnership for Zero Leprosy

The COVID-19 pandemic has strongly impacted leprosy control and prevention, and in response, GPZL has established three working groups to address the leprosy community’s key challenges during the global health crisis, and spearhead emergency response. This article is an update on their progress.

Read Article >